Phase 4 Biomarkers Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod
BiomarkersHSIL, High Grade Squamous Intraepithelial LesionsVaginal Microbiome
Barretos Cancer Hospital96 enrolled1 locationNCT06356012
Completed
Phase 4
Relationship of serological levels for death receptors (TNFR1, TRAIL -R2, FAS ) With early pancreatic ß cell Apoptosis and Follow up after DPP4 inhibitors treatment in Syrian type 2 diabetic and impaired fasting glucose patients
the research problem is to study serum apoptotic biomarkers and inflammatory mediators in naive drug prediabetes to determine whether drug intervention (DPP4inhibitors ) can slow down or reverse apoptosis of pancreatic beta cell in order to limit conversion prediabetes to T2DM .
rama ayash -Damascus university ,-pharmacy college88 enrolled1 locationACTRN12624001135505
Completed
Phase 4
The potential of selenium supplements provided as selenium-enriched dairy protein or yeast selenium to improve selenium status
Plasma selenium concentration
Levels of biomarkers in rectal epithelium
Professor Graeme Young MD, FRACP20 enrolled1 locationACTRN12607000345482